The PE Ratio as of November 2024 (TTM) for Galectin Therapeutics Inc. (GALT) is -3.81

According to Galectin Therapeutics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.81. This represents a change of 20.67% compared to the average of -3.16 of the last 4 quarters.

Galectin Therapeutics Inc. (GALT) Historical PE Ratio (quarterly & annually)

How has GALT PE Ratio performed in the past?

The mean historical PE Ratio of Galectin Therapeutics Inc. over the last ten years is -4.98. The current -3.81 PE Ratio has changed 7.55% with respect to the historical average. Over the past ten years (40 quarters), GALT's PE Ratio was at its highest in in the December 2022 quarter at -0.56. The PE Ratio was at its lowest in in the March 2019 quarter at -23.67.

Galectin Therapeutics Inc. (GALT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Galectin Therapeutics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Galectin Therapeutics Inc. (GALT) Average PE Ratio

How has GALT PE Ratio performed in the past?

The current PE Ratio of Galectin Therapeutics Inc. (GALT) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Galectin Therapeutics Inc. (GALT) PE Ratio vs. Peers

How is GALT’s PE Ratio compared to its peers?

Galectin Therapeutics Inc.’s PE Ratio is greater than Madrigal Pharmaceuticals, Inc. (-14.57), greater than Viking Therapeutics, Inc. (-58.83), less than Sarepta Therapeutics, Inc. (89.43), less than Hepion Pharmaceuticals, Inc. (-0.20), greater than PTC Therapeutics, Inc. (-7.34), greater than Intercept Pharmaceuticals, Inc. (-91.78), greater than Terns Pharmaceuticals, Inc. (-5.12), greater than Akero Therapeutics, Inc. (-9.58), greater than Reata Pharmaceuticals, Inc. (-20.07), greater than DiaMedica Therapeutics Inc. (-9.26), less than Milestone Pharmaceuticals Inc. (-2.85), greater than Seres Therapeutics, Inc. (-4.61), less than Inhibikase Therapeutics, Inc. (-1.05), less than Oncolytics Biotech Inc. (-3.67), less than 89bio, Inc. (-3.25), greater than Pliant Therapeutics, Inc. (-3.91), greater than Arcellx, Inc. (-120.42), greater than Stoke Therapeutics, Inc. (-6.11),

Build a custom stock screener for Galectin Therapeutics Inc. (GALT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Galectin Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Galectin Therapeutics Inc. (GALT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Galectin Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.